在眼科中使用抗血管内皮生长因子疗法
Seher Koksaldi1, Omer Karti2, Ali Osman Saatci2
1Department of Ophthalmology, Agri Ibrahim Cecen University Faculty of Medicine, Agri, Turkiye.
Medical hypothesis, discovery & innovation ophthalmology journal
|October 20, 2025
概括
抗血管内皮生长因子 (anti-VEGF) 疗法彻底改变了视网膜疾病的治疗方法,为诸如黄斑变性和糖尿病视网膜病变等疾病提供了改善的视力. 生物类似药和新药提供了具有成本效益和持久性的选择.
科学领域:
- 眼科医生 眼科 眼科
- 医学研究 医学研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 视网膜疾病如AMD,糖尿病视网膜病变和RVO导致全球显著的视力损失.
- 抗VEGF疗法已经改变了管理,保护和改善视力.
- 本审查涵盖了抗VEGF的开发,应用和新兴用途,包括生物类似药.
研究的目的:
- 在眼科中提供对抗VEGF疗法的全面审查.
- 讨论这些疗法的开发,临床应用和新出现的指示.
- 在审查中包括有关生物类似药物的信息.
主要方法:
- 在PubMed/MEDLINE进行了全面的文献搜索,截至2025年7月.
- 包括研究:临床试验,元分析,观察性研究和临床前研究.
- 关键词包括"抗VEGF疗法"",生物类似制药"",视网膜疾病"和特定药物的名称.
主要成果:
- 抗VEGF药物对于管理新血管AMD,糖尿病黄斑,RVO和早产视网膜病变至关重要.
- 新的药物,如布罗卢齐祖马布和法里西马布,提供了更好的耐用性和结果.
- 生物类似药提供了成本效益较高的替代品,治疗在各种非标签指示中显示出前景.
结论:
- 抗VEGF疗法已经彻底改变了眼科,提供了拯救视力的治疗方法.
- 由于疗效和安全性,这些疗法是新血管视网膜疾病的标准.
- 它们对现代眼睛护理产生了变革性的影响.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:27Open Angle Glaucoma: Treatment
958
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
958
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
01:10Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
438
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
438